# Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer

Source: https://onco.cc/trials/nct05220800/  
OnCo record `nct05220800` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial in colorectal cancer, run by Zealand University Hospital, not yet recruiting.

## Summary

Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer is a phase 2, randomised interventional study registered as NCT05220800 by Zealand University Hospital, with a registry enrolment figure of 134 participants, started 2022-03-01 and due to reach its primary completion in 2024-03-01. Interventions recorded: Iron(III)isomaltoside; Placebo. Conditions listed: Iron-deficiency; Colorectal Cancer. Primary outcome: Change in oxygen uptake at the anaerobic threshold; Change in neutrophile to lymphocyte ratio (NLR); Changes in T-cell function - mRNA expression analysis. Colorectal eligibility wording from the registry: "* Planned for curative intended elective colon or rectum cancer surgery". Sites: Denmark. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Also known as: NAIDIC
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT05220800
- Phase: 2
- Setting: Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer: A Double Blinded Clinical Randomized Trial
- Sponsor: Zealand University Hospital
- Enrolled: 134

## Sources

- ClinicalTrials.gov NCT05220800: https://clinicaltrials.gov/study/NCT05220800

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct05220800.json